Back to Search
DOUGLAS HORST, MD
MD
Gastroenterology Physician
NPI: 1518957224IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
39297(MA)
Education
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO SCHOOL OF MEDICINE
Class of 1974
Research & Publications (20)
The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer.
PMID 19298008·Cancer·2009
8-other
The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer.
PMID 19621338·J Pathol·2009
8-other
CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer.
PMID 19403300·Eur J Cancer·2009
8-other
Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer.
PMID 19626493·Cancer Invest·2009
4-observational
Invasion associated up-regulation of nuclear factor kappaB target genes in colorectal cancer.
PMID 19658179·Cancer·2009
4-observational
CD133 expression is an independent prognostic marker for low survival in colorectal cancer.
PMID 18781171·Br J Cancer·2008
8-other
Comparative expression analysis of Pax3 and Pax7 during mouse myogenesis.
PMID 16323077·Int J Dev Biol·2006
4-observational
p16INK4a is a beta-catenin target gene and indicates low survival in human colorectal tumors.
PMID 18951899·Gastroenterology·2009
8-other
Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle.
PMID 19557156·PLoS Pathog·2009
7-preclinical
Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
PMID 19274709·J Pathol·2009
4-observational
Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation.
PMID 19201886·J Immunol·2009
7-preclinical
Synthesis and biological evaluation of a chitobiose-based peptide N-glycanase inhibitor library.
PMID 19072094·J Org Chem·2009
8-other
Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
PMID 18852257·Gut·2009
4-observational
Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
PMID 18977445·Semin Cancer Biol·2008
6-review
Betacellulin stimulates growth of the mouse intestinal epithelium and increases adenoma multiplicity in Apc+/Min mice.
PMID 18656477·FEBS Lett·2008
7-preclinical
A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates.
PMID 17620360·J Exp Med·2007
7-preclinical
Leydig cell tumors of the testis: a molecular-cytogenetic study based on a large series of patients.
PMID 17273737·Oncol Rep·2007
8-other
Sertoli-Leydig cell tumours of the ovary and testis: a CGH and FISH study.
PMID 17235570·Virchows Arch·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 330 BROOKLINE AVE
BOSTON, MA 02215 - Phone
- (617) 632-8623
Quick Facts
- NPI
- 1518957224
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 52
- Publications
- 20
Are you this provider?
Claim Your Profile